美國的體外診斷市場:Medtech 360
市場調查報告書
商品編碼
1128138

美國的體外診斷市場:Medtech 360

In Vitro Diagnostics | Medtech 360 | Market Insights | United States

出版日期: | 出版商: Clarivate | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

COVID-19大流行給予美國的體外診斷市場負面影響,2020年檢查數量與銷售額減少。可是,經過恢復期,到2031年預計該市場緩慢成長。原動力是美國人口的高齡化,慢性疾病和感染疾病的發生率上升,價值為基礎的醫療保健的轉移,自動化體外診斷系統的開發,診斷準確度的提高,所需時間的縮短,預計促進更新的檢驗的普及。

本報告提供美國的體外診斷市場相關調查,市場概要,以及各市場區隔的市場概要與預測資料,競爭趨勢等資訊。

目錄

美國

概要

摘要整理

主要的報告的更新

COVID-19分析

  • 對市場的影響
  • 主要市場預測的變化與假設
  • 競爭的影響

體外診斷市場

  • 市場概況
  • 市場定義
  • 市場預測資料
  • 競爭力的亮點
  • 市場佔有率
  • 競爭要素與策略
    • 臨床資料
    • 產品的改善與創新
    • 合併,收購,及夥伴關係
    • 產品投資組合管理
  • 市場趨勢

生物化學檢驗市場

  • 市場概況
  • 市場定義
  • 市場預測資料
    • 一般化學實驗
    • 糖尿病檢驗
    • 治療藥監測實驗
    • 濫用藥物檢驗
    • 特定的蛋白質檢驗
    • 心臟標記
    • 血氣
  • 競爭力的亮點
  • 市場佔有率
  • 競爭要素與策略

免疫檢驗市場

  • 市場概況
  • 市場定義
  • 市場預測資料
    • 過敏檢驗
    • 貧血檢驗
    • 骨骼代謝檢驗
    • 心臟標記檢驗
    • 不孕/荷爾蒙檢驗
    • 傳染病檢查
    • 特定蛋白質檢驗
    • 甲狀腺檢驗
    • 腫瘤標記(癌症篩檢)檢驗
  • 競爭力的亮點
  • 市場佔有率
  • 競爭要素與策略

微生物檢驗市場

  • 市場概況
  • 市場定義
  • 市場預測資料
    • 病理培養檢驗
    • 血液培養檢驗
    • 鑑定/抗生素敏銳度實驗
  • 競爭力的亮點
  • 市場佔有率
  • 競爭要素與策略

血液凝固檢查市場

  • 市場概況
  • 市場定義
  • 市場預測資料
    • 一般篩檢及抗凝固監測檢驗
    • 凝血酵素原時間(PT)檢驗
    • D-Dimer檢驗
    • 纖維蛋白形成及分解實驗
  • 競爭力的亮點
  • 市場佔有率
  • 競爭要素與策略

分子診斷檢驗市場

  • 市場概況
  • 市場定義
  • 市場預測資料
    • 傳染病檢查
  • 競爭力的亮點
  • 市場佔有率
  • 競爭要素與策略

附錄

調查手法

簡介目錄

The COVID-19 pandemic has negatively impacted the US IVD market, resulting in test volumes and revenue declines in 2020. However, following a period of recovery, the market will grow modestly through 2031, driven by the aging US population, the rise in incidences of chronic and infectious, diseases and the shift toward value-based healthcare, which will fuel the uptake of newer tests with the development of automated IVD systems, improved diagnostic accuracy and reduced turnaround time. The continuous increase in the launch of IVD products being launched by key players is also fueling the growth of the market

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2031.

The COVID-19 pandemic has negatively impacted the US IVD market to some extent.

  • How strongly has the US IVD market been impacted by the COVID-19 pandemic?
  • Which test types and segments have been most impacted?
  • At what pace is the market recovering?

The use of MDx tests will expand rapidly over the forecast period.

  • Which MDx tests will experience the highest growth throughout the forecast period?
  • How will adoption of MDx tests affect the other test segments in the IVD market?

The PAMA reimbursement revision will promote widespread pricing pressures and increase laboratory consolidation in the US.

  • How must vendors adjust their strategies to adapt to this trend?
  • How will the growth prospects of the market be affected?
  • How will test volumes between the different facility types be affected?

The IVD competitive landscape consists of large MNCs as well as smaller niche competitors specializing in specific segments and diseases.

  • How do strategies differ between MNCs and smaller companies in this space?
  • What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?

Table of Contents

United States

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Procedures Covered
  • Products Covered

Key Report Updates

COVID-19 Analysis

  • Market Impact
  • Major Market Forecast Changes and Assumptions
  • Competitive Impact

In Vitro Diagnostics Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Clinical Data
    • Product Improvements and Innovations
    • Mergers, Acquisitions, and Partnerships
    • Product Portfolio Management
  • Market Developments

Clinical Chemistry Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • General Chemistry Tests
    • Diabetes Tests
    • Therapeutic Drug Monitoring Tests
    • Drug of Abuse Testing
    • Specific Protein Tests
    • Cardiac Marker
    • Blood Gas
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Immunoassay Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Allergy Tests
    • Anemia Tests
    • Bone Metabolism Tests
    • Cardiac Marker Tests
    • Fertility/Hormone Tests
    • Infectious Disease Tests
    • Specific Protein
    • Thyroid Tests
    • Tumor Marker Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Microbiology Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Pathological Culture Tests
    • Blood Culture Tests
    • Identification/Antibiotic Susceptibility Testing
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Hematology and Coagulation Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • General Screening and Anticoagulation Monitoring Tests
    • Prothrombin Time Tests
    • D-Dimer Tests
    • Fibrin Formation and Degradation Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Molecular Diagnostic Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
    • Infectious Disease Tests
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Appendix

  • Abbreviations
  • Bibliography

Methodology

  • Core Country Coverage Methodology
  • Research Methodology
  • Marketrack Methodology
  • PriceTrack Methodology
  • Forecast Methodology
  • Supplemental Country Coverage Methodology
  • Base-Year Ratio Analysis
  • Market Forecasting

Tables and Figures

  • Factors Impacting the IVD Market, by Application, US
  • IVD Market, by Application, US (USD), 2019-2031
  • IVD Market Landscape, US (USD), 2021 and 2031
  • Competitive Factors and Strategies, by Product Type, US
  • IVD Test Revenue Market Share Rankings, by Application, US, 2021
  • Companies Mentioned
  • Recent Events in the IVD Market, US
  • IVD Procedures Covered, US
  • IVD Products1 Covered, US
  • COVID-19 Impact Assessment Summary, IVD Market, US
  • IVD Market Scenario Forecast, US (USD), 2019-2031 (Excluding COVID-19 Impact)
  • IVD Market, by Application, US (USD), 2019-2031 (Including COVID-19 Impact)
  • COVID-19 Competitive Factors and Strategies, IVD Market, US
  • COVID-19 Financial Impact and Competitor Insights
  • Factors Impacting the IVD Market, by Application, US
  • IVD Market, by Application, US (USD), 2019-2031
  • IVD Market, by Product Type, US (USD), 2019-2031
  • IVD Market, by Setting, US (USD), 2019-2031
  • IVD Market, by Application, US (USD), 2019-2031
  • IVD Test Market, by Application, US (USD), 2019-2031
  • IVD Instrumentation Market, by Application, US (USD), 2019-2031
  • IVD Test Revenue Market Shares, US, 2021
  • IVD Test Revenue Market Shares, by Application, US, 2021
  • Competitive Factors and Strategies, by Product Type, US
  • Recent Events in the IVD Market, US
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2031
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2031
  • Clinical Chemistry Test Market, by Setting, US (USD), 2019-2031
  • Clinical Chemistry Test Market, by Test Type, US (USD), 2019-2031
  • Alanine Aminotransferase Tests, by Setting, US, 2019-2031
  • Alkaline Phosphatase Tests, by Setting, US, 2019-2031
  • Aspartate Aminotransferase Tests, by Setting, US, 2019-2031
  • Bilirubin Tests, by Setting, US, 2019-2031
  • Calcium Tests, by Setting, US, 2019-2031
  • Comprehensive Metabolic Panel Tests, by Setting, US, 2019-2031
  • Creatinine Tests, by Setting, US, 2019-2031
  • Electrolyte Panel Tests, by Setting, US, 2019-2031
  • Hepatic Panel Tests, by Setting, US, 2019-2031
  • Human Chorionic Gonadotropin Tests, by Setting, US, 2019-2031
  • Lactate Tests, by Setting, US, 2019-2031
  • Lactate Dehydrogenase Tests, by Setting, US, 2019-2031
  • Lipase Tests, by Setting, US, 2019-2031
  • Lipid Panel Tests, by Setting, US, 2019-2031
  • Magnesium Tests, by Setting, US, 2019-2031
  • Metabolic Panel including Total Calcium Tests, by Setting, US, 2019-2031
  • Phosphorus Tests, by Setting, US, 2019-2031
  • Potassium Tests, by Setting, US, 2019-2031
  • Total Protein Tests, by Setting, US, 2019-2031
  • Uric Acid Tests, by Setting, US, 2019-2031
  • Other General Chemistry Tests, by Setting, US, 2019-2031
  • Blood Glucose (Non-Reagent-Strip) Tests, by Setting, US, 2019-2031
  • Blood Glucose Reagent Strip Tests, by Setting, US, 2019-2031
  • Glucose Tolerance Tests, by Setting, US, 2019-2031
  • HbA1c Tests, by Setting, US, 2019-2031
  • Insulin Tests, by Setting, US, 2019-2031
  • Microalbumin Quantitative Tests, by Setting, US, 2019-2031
  • Urine Glucose Tests, by Setting, US, 2019-2031
  • Other Diabetes Tests, by Setting, US, 2019-2031
  • Carbamazepine Tests, by Setting, US, 2019-2031
  • Cyclosporine Tests, by Setting, US, 2019-2031
  • Digoxin Tests, by Setting, US, 2019-2031
  • Phenobarbital Tests, by Setting, US, 2019-2031
  • Phenytoin (Total) Tests, by Setting, US, 2019-2031
  • Tacrolimus Tests, by Setting, US, 2019-2031
  • Theophylline Tests, by Setting, US, 2019-2031
  • Valproic Acid (Total) Tests, by Setting, US, 2019-2031
  • Vancomycin Tests, by Setting, US, 2019-2031
  • Other TDM Tests, by Setting, US, 2019-2031
  • Ethanol Tests, by Setting, US, 2019-2031
  • Acetaminophen Tests, by Setting, US, 2019-2031
  • Salicylate Tests, by Setting, US, 2019-2031
  • Antinuclear Antibody Tests, by Setting, US, 2019-2031
  • Haptoglobin Tests, by Setting, US, 2019-2031
  • Homocysteine Tests, by Setting, US, 2019-2031
  • Prealbumin Tests, by Setting, US, 2019-2031
  • Rheumatoid Factor Tests, by Setting, US, 2019-2031
  • Somatomedin Tests, by Setting, US, 2019-2031
  • Other Specific Protein Tests, by Setting, US, 2019-2031
  • Apolipoprotein Tests, by Setting, US, 2019-2031
  • Cholesterol Tests, by Setting, US, 2019-2031
  • C-Reactive Protein Tests, by Setting, US, 2019-2031
  • High Sensitivity C-Reactive Protein Tests, by Setting, US, 2019-2031
  • Low Density Lipoprotein Tests, by Setting, US, 2019-2031
  • Triglyceride Tests, by Setting, US, 2019-2031
  • Other Cardiac Marker Tests, by Setting, US, 2019-2031
  • Arterial Blood Gas Tests, by Setting, US, 2019-2031
  • Chloride Tests, by Setting, US, 2019-2031
  • Urea Nitrogen Tests, by Setting, US, 2019-2031
  • Other Blood Gas Tests, by Setting, US, 2019-2031
  • Clinical Chemistry Test Revenue Market Shares, US, 2021
  • Clinical Chemistry Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2031
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2031
  • Immunoassay Test Market, by Setting, US (USD), 2019-2031
  • Immunoassay Test Market, by Test Type, US (USD), 2019-2031
  • Allergy IgA, IgD, IgG, IgM Tests, by Setting, US, 2019-2031
  • Allergy IgE Tests, by Setting, US, 2019-2031
  • Immunoglobulin Subclasses Tests, by Setting, US, 2019-2031
  • Erythropoietin Tests, by Setting, US, 2019-2031
  • Ferritin Tests, by Setting, US, 2019-2031
  • Intrinsic Factor Antibody Tests, by Setting, US, 2019-2031
  • Iron Tests, by Setting, US, 2019-2031
  • Iron Binding Capacity Tests, by Setting, US, 2019-2031
  • Vitamin B-12 Tests, by Setting, US, 2019-2031
  • HGH Tests, by Setting, US, 2019-2031
  • Parathormone Tests, by Setting, US, 2019-2031
  • Vitamin D 25 Hydroxy Tests, by Setting, US, 2019-2031
  • Creatine Kinase Tests, by Setting, US, 2019-2031
  • CK-MB Tests, by Setting, US, 2019-2031
  • BNP Tests, by Setting, US, 2019-2031
  • Troponin Tests, by Setting, US, 2019-2031
  • ACTH Tests, by Setting, US, 2019-2031
  • Estradiol Tests, by Setting, US, 2019-2031
  • FSH Tests, by Setting, US, 2019-2031
  • LH Tests, by Setting, US, 2019-2031
  • Progesterone Tests, by Setting, US, 2019-2031
  • Prolactin Tests, by Setting, US, 2019-2031
  • Testosterone Tests, by Setting, US, 2019-2031
  • Other Fertility/Hormone Tests, by Setting, US, 2019-2031
  • Acute Hepatitis Tests, by Setting, US, 2019-2031
  • CMV Tests, by Setting, US, 2019-2031
  • Epstein-Barr Virus Tests, by Setting, US, 2019-2031
  • Hepatitis A Tests, by Setting, US, 2019-2031
  • Hepatitis B Tests, by Setting, US, 2019-2031
  • Hepatitis C Tests, by Setting, US, 2019-2031
  • HIV-1/HIV-2 Tests, by Setting, US, 2019-2031
  • HSV Tests, by Setting, US, 2019-2031
  • HSV Type 2 Tests, by Setting, US, 2019-2031
  • HTLV or HIV Tests, by Setting, US, 2019-2031
  • Influenza A/B Tests, by Setting, US, 2019-2031
  • Lyme Disease Tests, by Setting, US, 2019-2031
  • Microsomal Antibodies Tests, by Setting, US, 2019-2031
  • Nephelometry Tests, by Setting, US, 2019-2031
  • Parvovirus Tests, by Setting, US, 2019-2031
  • Respiratory Syncytial Virus Tests, by Setting, US, 2019-2031
  • Rotavirus Tests, by Setting, US, 2019-2031
  • Rubella Tests, by Setting, US, 2019-2031
  • Treponema Pallidum Tests, by Setting, US, 2019-2031
  • Varicella-Zoster Virus Tests, by Setting, US, 2019-2031
  • Other Infectious Disease Tests, by Setting, US, 2019-2031
  • Albumin Tests, by Setting, US, 2019-2031
  • Alpha-1 Antitrypsin Tests, by Setting, US, 2019-2031
  • Gamma-Glutamyl Transferase Tests, by Setting, US, 2019-2031
  • Thyroxine (Free) Tests, by Setting, US, 2019-2031
  • Thyroglobulin Tests, by Setting, US, 2019-2031
  • Thyroid (T3) Tests, by Setting, US, 2019-2031
  • Thyroid (T3 or T4) Tests, by Setting, US, 2019-2031
  • Thyroxine (Total) Tests, by Setting, US, 2019-2031
  • TSH Tests, by Setting, US, 2019-2031
  • Alpha-Fetoprotein Serum Tests, by Setting, US, 2019-2031
  • Beta-2 Microglobulin Tests, by Setting, US, 2019-2031
  • CA 125 Tests, by Setting, US, 2019-2031
  • CA 15-3 Tests, by Setting, US, 2019-2031
  • CA 19-9 Tests, by Setting, US, 2019-2031
  • Carcinoembryonic Antigen Tests, by Setting, US, 2019-2031
  • PSA (Free) Tests, by Setting, US, 2019-2031
  • PSA (Total) Tests, by Setting, US, 2019-2031
  • Other Tumor Marker Tests, by Setting, US, 2019-2031
  • Immunoassay Test Revenue Market Shares, US, 2021
  • Immunoassay Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • Microbiology Test Market, by Product Type, US (USD), 2019-2031
  • Microbiology Test Market, by Product Type, US (USD), 2019-2031
  • Microbiology Test Market, by Setting, US (USD), 2019-2031
  • Microbiology Test Market, by Test Type, US (USD), 2019-2031
  • Salmonella and Shigella (Stool Culture) Tests, by Setting, US, 2019-2031
  • Other Pathogen (Stool Culture) Tests, by Setting, US, 2019-2031
  • Mycobacteria Culture Tests, by Setting, US, 2019-2031
  • Aerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2031
  • Anaerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2031
  • Urine Bacteria Culture Tests, by Setting, US, 2019-2031
  • Blood Culture Tests, by Setting, US, 2019-2031
  • Aerobic Culture Identification Tests, by Setting, US, 2019-2031
  • Anaerobic Culture Identification Tests, by Setting, US, 2019-2031
  • Immunologic Culture Identification Tests, by Setting, US, 2019-2031
  • MIC Tests, by Setting, US, 2019-2031
  • Microbe Susceptible Disk Tests, by Setting, US, 2019-2031
  • Presumptive Pathogenic Organisms Culture Tests, by Setting, US, 2019-2031
  • Yeast Identification Tests, by Setting, US, 2019-2031
  • Other ID/AST Tests, by Setting, US, 2019-2031
  • Microbiology Test Revenue Market Shares, US, 2021
  • Microbiology Test Revenue Market Shares, US, 2021
  • Competitive Factors and Strategies, US
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2031
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2031
  • Hematology and Coagulation Test Market, by Setting, US (USD), 2019-2031
  • Hematology and Coagulation Test Market, by Test Type, US (USD), 2019-2031
  • Automated Platelet Count Tests, by Setting, US, 2019-2031
  • Blood Smear with Differential White Blood Cell Count Tests, by Setting, US, 2019-2031
  • Complete CBC Automated Tests, by Setting, US, 2019-2031
  • Complete CBC with Automated White Blood Cell Count Tests, by Setting, US, 2019-2031
  • Erythrocyte Sedimentation Rate Tests, by Setting, US, 2019-2031
  • Hematocrit Tests, by Setting, US, 2019-2031
  • Hemoglobin Tests, by Setting, US, 2019-2031
  • Leukocyte Tests, by Setting, US, 2019-2031
  • Red Blood Cell Count Tests, by Setting, US, 2019-2031
  • Reticulocyte Tests, by Setting, US, 2019-2031
  • Sickle Cell Screen Tests, by Setting, US, 2019-2031
  • Transferrin Tests, by Setting, US, 2019-2031
  • Other General Screening and Anticoagulation Monitoring Tests, by Setting, US, 2019-2031
  • Prothrombin Time Tests, by Setting, US, 2019-2031
  • D-Dimer Tests, by Setting, US, 2019-2031
  • aPTT Tests, by Setting, US, 2019-2031
  • Fibrinogen Tests, by Setting, US, 2019-2031
  • Hematology and Coagulation Test Revenue Market Shares, US, 2021
  • Hematology and Coagulation Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • MDx Test Market, by Product Type, US (USD), 2019-2031
  • MDx Test Market, by Product Type, US (USD), 2019-2031
  • MDx Test Market, by Setting, US (USD), 2019-2031
  • Chlamydia Tests, by Setting, US, 2019-2031
  • Clostridium Difficile Tests, by Setting, US, 2019-2031
  • Gonorrhea Tests, by Setting, US, 2019-2031
  • Hepatitis C Tests, by Setting, US, 2019-2031
  • HIV-1 Tests, by Setting, US, 2019-2031
  • HPV Tests, by Setting, US, 2019-2031
  • HSV Tests, by Setting, US, 2019-2031
  • Staphylococcus Aureus Tests, by Setting, US, 2019-2031
  • Streptococcus Group A Tests, by Setting, US, 2019-2031
  • Unspecified Infectious Agent Tests, by Setting, US, 2019-2031
  • Other Infectious Disease Tests, by Setting, US, 2019-2031
  • MDx Test Revenue Market Shares, US, 2021
  • MDx Test Revenue Market Shares, by Product Type, US, 2021
  • Competitive Factors and Strategies, US
  • Abbreviations